These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 10803275

  • 1. Prostaglandin therapy of peripheral occlusive arterial disease.
    Linhart J.
    Sb Lek; 1998; 99(4):355-62. PubMed ID: 10803275
    [Abstract] [Full Text] [Related]

  • 2. [Acral skin circulation following intra-arterial infusion of vasodilating substances in patients with intermittent claudication].
    Scheffler A, Rieger H.
    Med Klin (Munich); 1990 Jan 15; 85(1):1-5. PubMed ID: 2314351
    [Abstract] [Full Text] [Related]

  • 3. [Results of intra-arterial administration of PGE1 prostaglandin].
    Ciostek P, Kostewicz W, Górski G.
    Wiad Lek; 1994 Oct 15; 47(19-20):750-2. PubMed ID: 7483622
    [Abstract] [Full Text] [Related]

  • 4. [Results of the treatment of peripheral arterial diseases with PGE1].
    Borkowski M, Kruk M, Królicki L, Wojtal E, Malmurowicz L, Górewicz R, Laszuk D.
    Pol Tyg Lek; 1994 Oct 15; 45(25-26):505-8. PubMed ID: 2287566
    [Abstract] [Full Text] [Related]

  • 5. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
    Mohler ER, Klugherz B, Goldman R, Kimmel SE, Wade M, Sehgal CM.
    Vasc Med; 2000 Oct 15; 5(4):231-7. PubMed ID: 11213235
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG, Nelson SR, Hampton KK, Casali B, Boothby M, Prentice CR.
    Blood Coagul Fibrinolysis; 1990 Oct 15; 1(4-5):385-8. PubMed ID: 2133215
    [Abstract] [Full Text] [Related]

  • 7. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct 15; 20(4):358-62. PubMed ID: 11038148
    [Abstract] [Full Text] [Related]

  • 8. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI, Edvinsson ML, Angus Deveber G.
    Int Angiol; 2003 Jun 15; 22(2):141-7. PubMed ID: 12865879
    [Abstract] [Full Text] [Related]

  • 9. Enhancing foot skin blood flux in peripheral vascular disease using intermittent pneumatic compression: controlled study on claudicants and grafted arteriopaths.
    Delis KT, Husmann MJ, Nicolaides AN, Wolfe JH, Cheshire NJ.
    World J Surg; 2002 Jul 15; 26(7):861-6. PubMed ID: 12096335
    [Abstract] [Full Text] [Related]

  • 10. [Circadian variations of cutaneous blood flow in normal subjects and in patients with peripheral arteriopathies. Effect of PGE1 and alpha-cyclodextrin].
    Laurora G, Belcaro G.
    Minerva Cardioangiol; 1998 Oct 15; 46(10 Suppl 1):45-9. PubMed ID: 10658444
    [Abstract] [Full Text] [Related]

  • 11. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T, Griesshaber J, Rogatti W, Kistner O, Hsu E, Jansen T, Diehm C.
    Vasa Suppl; 1991 Oct 15; 33():341-2. PubMed ID: 1788749
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T, Eckstein H, Weiss C, Diehm C.
    Vasc Med; 1998 Oct 15; 3(3):171-5. PubMed ID: 9892509
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989 Oct 15; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
    D'Eri A, Martini R, Cordova RM, Trevisan G, Andreozzi GM.
    Minerva Cardioangiol; 2002 Jun 15; 50(3):239-44. PubMed ID: 12107403
    [Abstract] [Full Text] [Related]

  • 15. [Prostaglandin E1 in intermittent claudication].
    Scheffler P, de la Hamette D, Rogatti W.
    Vasa Suppl; 1992 Jun 15; 35():147-8. PubMed ID: 1481022
    [No Abstract] [Full Text] [Related]

  • 16. Peripheral sympathetic autoregulation in arterial calf inflow enhancement with intermittent pneumatic compression.
    Delis KT, Nicolaides AN, Wolfe JH.
    Eur J Vasc Endovasc Surg; 2001 Oct 15; 22(4):317-25. PubMed ID: 11563890
    [Abstract] [Full Text] [Related]

  • 17. [Increasing transcutaneous PO2 in arteriopathies during treatment with PGE1 alpha-cyclodextrin].
    Belcaro G, Cesarone MR.
    Minerva Cardioangiol; 1998 Oct 15; 46(10 Suppl 1):37-43. PubMed ID: 10658443
    [Abstract] [Full Text] [Related]

  • 18. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K, Ikeda U, Murakami Y, Yoshioka T, Shimada K.
    Am Heart J; 2003 Feb 15; 145(2):330-3. PubMed ID: 12595852
    [Abstract] [Full Text] [Related]

  • 19. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P, de la Hamette D, Leipnitz G.
    Vasa Suppl; 1991 Feb 15; 33():343-4. PubMed ID: 1788750
    [Abstract] [Full Text] [Related]

  • 20. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P, Maurel A.
    Angiology; 1998 Feb 15; 49(2):105-14. PubMed ID: 9482510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.